This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

U.S. Court of Appeals for the 9th Circuit

Jun. 5, 2017

9th Circuit revives suit against drugmakers over man's death

The 9th U.S. Circuit Court of Appeals on Friday revived a lawsuit against pharmaceutical companies accused of failing to disclose a rare yet significant side effect that allegedly led to the death of the plaintiffs' son.

By Joshua Sebold
Daily Journal Staff Writer

The 9th U.S. Circuit Court of Appeals on Friday revived a lawsuit against pharmaceutical companies accused of failing to disclose a rare yet significant side effect that allegedly led to the death of the plaintiffs' son.

Teva Pharmaceuticals USA Inc. and GlaxoSmithKline LLC persuaded a district court judge to dismiss the negligence and strict liability lawsuit, but the 9th Circuit panel overtu...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up